Patients with psychosis may benefit from therapeutic effects found to be derived from cannabidiol (CBD), a naturally occurring constituent of cannabis, according to research published Aug. 29 in JAMA Psychiatry.

Brain MRIs have revealed that the anti-inflammatory drug ibudilast may slow down atrophy in patients with progressive multiple sclerosis (MS), according to research published Aug. 30 in the New England Journal of Medicine.

The National Institute for Mental Health (NIMH) has granted two Pittsburgh-based researchers a five-year, $3.8 million grant to better identify and treat individuals with suicidal thoughts using functional MRI (fMRI).

Using MRI technology, researchers found that individuals who have a weaker connection between two regions of the brain are more likely to procrastinate, according to an article published Aug. 23 by Newsweek.

Researchers from Baylor University in Waco, Texas, found that pediatric patients with brain tumors who undergo radiation treatment are less likely to remember detailed events they’ve experienced after treatment, according to research published online Aug. 20 in Neuroscience.

A new clinical trial—brain xxygen optimization in severe traumatic brain injury, Phase 3 (BOOST-3)—will build off prior research with a goal of improving outcomes in those victims of severe TBI, according to a University of Michigan release.

Researchers studying MRI images of the functional connections in the brain have found that an individual's “functional fingerprint” may be used to distinguish individuals over the course of their lifetime, according to an article published Aug. 16 by Quanta Magazine.

“The less sleep you get, the less you want to socially interact. In turn, other people perceive you as more socially repulsive, further increasing the grave social-isolation impact of sleep loss,” said Matthew Walker, PhD, a professor of psychology and neuroscience at UC, Berkeley.